PLGA-based microspheres loaded with metformin hydrochloride: Modified double emulsion method preparation, optimization, characterization, and in vitro evaluation

Girard, 2022, How dysregulation of the immune system promotes diabetes mellitus and cardiovascular risk complications, Front Cardiovasc Med, 9, 991716, 10.3389/fcvm.2022.991716 2009, Diagnosis and classification of diabetes mellitus, Diabetes Care, 32, S62 2023 Itano, 2021, High urinary glucose is associated with improved renal prognosis in patients with diabetes mellitus, J Diabetes Investig., 12, 998, 10.1111/jdi.13428 Galicia-Garcia, 2020, Pathophysiology of type 2 diabetes mellitus, Int J Mol Sci, 21, 10.3390/ijms21176275 Cerf, 2013, Beta cell dysfunction and insulin resistance, Front Endocrinol, 4, 37, 10.3389/fendo.2013.00037 Galaviz, 2018, Lifestyle and the prevention of type 2 diabetes: a status report, Am J Lifestyle Med, 12, 4, 10.1177/1559827615619159 Adu, 2019, Enablers and barriers to effective diabetes self-management: a multinational investigation, PloS One, 14, e0217771, 10.1371/journal.pone.0217771 Cetin, 2016, Microparticulate and nanoparticulate drug delivery systems for metformin hydrochloride, Drug Deliv, 23, 2796, 10.3109/10717544.2015.1089957 Shafiei-Irannejad, 2017, New insights into antidiabetic drugs: possible applications in cancer treatment, Chem Biol Drug Design, 90, 1056, 10.1111/cbdd.13013 Baker, 2021, Should metformin remain the first-line therapy for treatment of type 2 diabetes?, Ther Adv Endocrinol Metab, 12, 10.1177/2042018820980225 Rena, 2017, The mechanisms of action of metformin, Diabetologia, 60, 1577, 10.1007/s00125-017-4342-z He, 2020, Metformin and systemic metabolism, Trends Pharmacol Sci, 41, 868, 10.1016/j.tips.2020.09.001 Hunter, 2018, Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase, Nat Med, 24, 1395, 10.1038/s41591-018-0159-7 Arnouts, 2013, Glucose-lowering drugs in patients with chronic kidney disease: a narrative review on pharmacokinetic properties, Nephrol Dial Transpl, 29, 1284, 10.1093/ndt/gft462 Vrettos, 2021, Gastroretentive technologies in tandem with controlled-release strategies: a potent answer to oral drug bioavailability and patient compliance implications, Pharmaceutics, 13, 10.3390/pharmaceutics13101591 McCreight, 2016, Metformin and the gastrointestinal tract, Diabetologia, 59, 426, 10.1007/s00125-015-3844-9 Dolder, 2017, Pharmacokinetics and pharmacodynamics of lysergic acid diethylamide in healthy subjects, Clin Pharmacokinet, 56, 1219, 10.1007/s40262-017-0513-9 Kanto, 2018, Effects of dosage and dosing frequency on the efficacy and safety of high-dose metformin in Japanese patients with type 2 diabetes mellitus, 9, 587 Kim, 2015, Metformin-associated lactic acidosis: predisposing factors and outcome, Endocrinol Metab, 30, 78, 10.3803/EnM.2015.30.1.78 Christofides, 2019, Practical insights into improving adherence to metformin therapy in patients with type 2 diabetes, Clin Diabetes, 37, 234, 10.2337/cd18-0063 Kenechukwu, 2022, Potential enhancement of metformin hydrochloride in solidified reverse micellar solution-based PEGylated lipid nanoparticles targeting therapeutic efficacy in diabetes treatment, Heliyon, 8, e09099, 10.1016/j.heliyon.2022.e09099 Patra, 2018, Nano based drug delivery systems: recent developments and future prospects, J Nanobiotechnol, 16, 71, 10.1186/s12951-018-0392-8 Khalid, 2017, Strategies for improving drug delivery: nanocarriers and microenvironmental priming, Exp Opin Drug Deliv, 14, 865, 10.1080/17425247.2017.1243527 Zhao, 2020, Drug delivery system in the treatment of diabetes mellitus, Front Bioeng Biotechnol, 8, 880, 10.3389/fbioe.2020.00880 Essa, 2020, The design of poly(lactide-co-glycolide) nanocarriers for medical applications, Front Bioeng Biotechnol, 8, 48, 10.3389/fbioe.2020.00048 Mansoor, 2019, Polymer-based nanoparticle strategies for insulin delivery, Polymers, 11, 10.3390/polym11091380 Fang, 2014, Trust, satisfaction, and online repurchase intention the moderating role of perceived effectiveness of E-commerce institutional mechanisms, MIS Q, 38, 10.25300/MISQ/2014/38.2.04 Hua, 2021, Poly(lactic-co-glycolic acid) microsphere production based on quality by design: a review, Drug Deliv, 28, 1342, 10.1080/10717544.2021.1943056 Gaber, 2021, Superhydrophobic surface for enhancing the bioavailability of salbutamol sulfate from cross-linked microspheres: formulation, characterization, and in vivo evaluation, Drug Design Dev Therap, 15, 2869, 10.2147/DDDT.S309078 Xu, 2017, Polymer degradation and drug delivery in PLGA-based drug–polymer applications: a review of experiments and theories, 105, 1692 Guo, 2015, Sustained release donepezil loaded PLGA microspheres for injection: preparation, in vitro and in vivo study, Asian J Pharm Sci, 10, 405, 10.1016/j.ajps.2015.06.001